Research Advancing Kentucky: Providing hope to pediatric cancer patients
Researchers at the University of Kentucky play an important role in advancing the health, well-being and future of our Commonwealth.
Much of that work is done with support from the National Institutes of Health (NIH). That support allows our researchers to find answers to many of the critical health issues facing Kentuckians.
John D’Orazio, M.D., Ph.D., is supported by the NIH’s National Cancer Institute, National Institute of General Medical Sciences and National Institute of Environmental Health Sciences.
D’Orazio is a professor in the Department of Pediatrics in the UK College of Medicine and holds joint faculty positions in physiology, pharmacology and nutritional sciences, and toxicology. He is also the chief of the Division of Hematology/Oncology – Pediatric at Kentucky Children’s Hospital.
As a physician-scientist, D’Orazio combines his research with active clinical practice, treating pediatric patients with cancer and blood disorders. His work seeks to find the genetic reasons that explain cancer diagnoses for children and young adults to improve care and screen their families for cancer risk.
“Our research uses at least five NIH-funded research facilities at UK, all embedded within the Markey Cancer Center,” said D’Orazio. “The main benefit of the research core facilities is that they offer expertise and state-of-the-art instrumentation that any one researcher couldn’t have on his or her own. Without these expert colleagues and the services that their core facilities provide, we could do none of this work.”
D'Orazio and other members of the research community shared the importance of NIH-funded research at UK in this video series from Research Communications.
Learn more about each featured researcher.
Research in the news:
Research Communications
